Receptor-Like Protein Tyrosine Phosphatases, Class 3
"Receptor-Like Protein Tyrosine Phosphatases, Class 3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of receptor-like protein tryosine phosphatases that contain a single cytosolic protein tyrosine phosphate domain and multiple extracellular fibronectin III-like domains.
MeSH Number(s)
D08.811.277.352.650.775.400.300
D12.644.360.587.300
D12.776.476.592.300
Concept/Terms
Receptor-Like Protein Tyrosine Phosphatases, Class 3- Receptor-Like Protein Tyrosine Phosphatases, Class 3
- Receptor Like Protein Tyrosine Phosphatases, Class 3
- Receptor-Like Protein Tyrosine Phosphatases, Class III
- Receptor Like Protein Tyrosine Phosphatases, Class III
Protein Tyrosine Phosphatase, Receptor Type H- Protein Tyrosine Phosphatase, Receptor Type H
- PTPRH Phosphatase
- Phosphatase, PTPRH
- SAP-1 Phosphatase
- Phosphatase, SAP-1
- SAP 1 Phosphatase
- Stomach Cancer-Associated Protein-Tyrosine Phosphatase
- Stomach Cancer Associated Protein Tyrosine Phosphatase
Protein Tyrosine Phosphatase, Receptor Type O- Protein Tyrosine Phosphatase, Receptor Type O
- PTPRO Phosphatase
- Phosphatase, PTPRO
- Protein Tyrosine Phosphatase Receptor omicron
- GLEPP1 Phosphatase
- Phosphatase, GLEPP1
- Glomerular Epithelial Protein 1
Protein Tyrosine Phosphatase, Receptor Type J- Protein Tyrosine Phosphatase, Receptor Type J
- PTPRJ Phosphatase
- Phosphatase, PTPRJ
- Protein-Tyrosine Phosphatase eta
- Phosphatase eta, Protein-Tyrosine
- Protein Tyrosine Phosphatase eta
- Density-Enhanced Phosphatase 1
- Density Enhanced Phosphatase 1
- DEP1 Phosphatase
Below are MeSH descriptors whose meaning is more general than "Receptor-Like Protein Tyrosine Phosphatases, Class 3".
Below are MeSH descriptors whose meaning is more specific than "Receptor-Like Protein Tyrosine Phosphatases, Class 3".
This graph shows the total number of publications written about "Receptor-Like Protein Tyrosine Phosphatases, Class 3" by people in Harvard Catalyst Profiles by year, and whether "Receptor-Like Protein Tyrosine Phosphatases, Class 3" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 2 | 2 |
Below are the most recent publications written about "Receptor-Like Protein Tyrosine Phosphatases, Class 3" by people in Profiles.
-
Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRH. PLoS Genet. 2022 09; 18(9):e1010362.
-
Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblasts. Sci Rep. 2022 02 18; 12(1):2847.
-
CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021 08 01; 204(3):312-325.
-
Syndecan-2 Attenuates Radiation-induced Pulmonary Fibrosis and Inhibits Fibroblast Activation by Regulating PI3K/Akt/ROCK Pathway via CD148. Am J Respir Cell Mol Biol. 2018 02; 58(2):208-215.
-
Pyk2 phosphorylation of VE-PTP downstream of STIM1-induced Ca2+ entry regulates disassembly of adherens junctions. Am J Physiol Lung Cell Mol Physiol. 2017 06 01; 312(6):L1003-L1017.
-
MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells. Exp Hematol. 2017 Feb; 46:56-61.e1.
-
Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis. Cell. 2016 Jan 14; 164(1-2):128-140.
-
Novel PTPRQ mutations identified in three congenital hearing loss patients with various types of hearing loss. Ann Otol Rhinol Laryngol. 2015 May; 124 Suppl 1:184S-92S.
-
Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation. Blood. 2015 Apr 16; 125(16):2530-43.
-
Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2. Ophthalmology. 2015 Mar; 122(3):545-54.